Treatment with IL‐15 or anti‐TIGIT resulted in significant suppression of tumour progression; notably, treatment with IL‐15 exhibited the most significant inhibition of tumour growth in Tigit−/− mice (Figure 7I). This evidence concerns the gene IL15 and neoplasm.